| 1 |
Muraine L, Bensalah M, Butler-Browne G, Bigot A, Trollet C, Mouly V, Negroni E. Update on anti-fibrotic pharmacotherapies in skeletal muscle disease. Curr Opin Pharmacol 2023;68:102332. [PMID: 36566666 DOI: 10.1016/j.coph.2022.102332] [Reference Citation Analysis]
|
| 2 |
Marine T, Melina M, Zoe W, Wei TL, Lucas R, Mark H, Joshua H, Fangfang L, Julyanne B, Yicong L, Elodie S, Samuel S, Katie D, Manjosh U, Marcela L, Christine E, Sato S, Akira S, Michael H, Pascal B, Mcnagny KM, Rossi FM. Mesenchymal Progenitors set the homeostatic inflammatory milieu via the TAK1-NFkB axis.. [DOI: 10.1101/2022.12.11.519940] [Reference Citation Analysis]
|
| 3 |
Wang X, Chen J, Homma ST, Wang Y, Smith GR, Ruf-Zamojski F, Sealfon SC, Zhou L. Diverse effector and regulatory functions of fibro/adipogenic progenitors during skeletal muscle fibrosis in muscular dystrophy. iScience 2023;26:105775. [PMID: 36594034 DOI: 10.1016/j.isci.2022.105775] [Reference Citation Analysis]
|
| 4 |
Gamboa-Gómez CI, Denise-Herrera M, Simental-Mendía LE, Zamilpa-Alvarez A, González-Cortazar M, Martínez-Aguilar G, Alvarado-Aguilar P, Morales-Castro EP, Ávila-Soto JA, Amador-Herrera JA, Guerrero-Romero F. Inhibitory effect of Mexican oregano (Lippia graveolens Kunth) extracts on digestive enzymes in vitro, and beneficial impact on carbohydrates and lipids absorption in vivo. J Ethnopharmacol 2022;297:115527. [PMID: 35817248 DOI: 10.1016/j.jep.2022.115527] [Reference Citation Analysis]
|
| 5 |
Theret M, Rempel L, Hashimoto J, Ritso M, Tung LW, Li FF, Messing M, Hughes M, Mcnagny K, Rossi F. Elevated numbers of infiltrating eosinophils accelerate the progression of Duchenne muscular dystrophy pathology in mdx mice. Development 2022;149. [DOI: 10.1242/dev.200112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Li N, Shan S, Li XQ, Chen TT, Qi M, Zhang SN, Wang ZY, Zhang LL, Wei W, Sun WY. G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases. Front Immunol 2021;12:822345. [PMID: 35111168 DOI: 10.3389/fimmu.2021.822345] [Reference Citation Analysis]
|
| 7 |
Molina T, Fabre P, Dumont NA. Fibro-adipogenic progenitors in skeletal muscle homeostasis, regeneration and diseases. Open Biol 2021;11:210110. [PMID: 34875199 DOI: 10.1098/rsob.210110] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 8 |
Hogarth MW, Uapinyoying P, Mázala DAG, Jaiswal JK. Pathogenic role and therapeutic potential of fibro-adipogenic progenitors in muscle disease. Trends Mol Med 2021:S1471-4914(21)00272-0. [PMID: 34750068 DOI: 10.1016/j.molmed.2021.10.003] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Contreras O, Rossi FMV, Theret M. Origins, potency, and heterogeneity of skeletal muscle fibro-adipogenic progenitors-time for new definitions. Skelet Muscle 2021;11:16. [PMID: 34210364 DOI: 10.1186/s13395-021-00265-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
|
